Search Results - david+morse

3 Results

Sort By:

Breast Tumor Targeted Fluorescence Guidance for Intraoperative Margin Assessment

This technology is an anti-CEACAM6 antibody tagged with fluorescent labels. The idea is that these fluorescent antibodies can be used for real-time molecular fluorescence imaging to help guide the surgical removal of a tumor. This technology is targeted toward breast cancer. Background: Over half of the 270,000 breast cancer diagnoses in the United...

Published: 6/24/2024 | Inventor(s): Daruka Mahadevan, David Morse, Marie Catherine Lee, Narges Tafreshi

Keywords(s):

Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Oncology

Toll-like Receptor 2 Ligands and Methods of Making and Using Thereof

Inventors at the University of Arizona have developed a set of 13 high-affinity toll-like receptor 2 (TLR2) agonists. In certain diseases, particularly pancreatic cancer, these receptors are overexpressed. TLR2 agonists are absorbed by these receptors. When the ligands are labeled with fluorescent proteins, the tumors can be identified. Additionally,...

Published: 4/3/2023 | Inventor(s): Josef Vagner, Mark Mclaughlin, David Morse

Keywords(s):

Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Biologics

Molecular Imaging of Cancer Cells in Vivo

This technology is a non-invasive method of detecting cancer using in vivo probes that target and bind to receptor cites on or around the cancerous growth. Applications: Cancer detection - identify and confirm possible tumors Optical imaging probe Advantages: As an optical imaging probe, there is a high sensitivity for ligand detection and...

Published: 4/3/2023 | Inventor(s): Josef Vagner, Amanda Huynh, Robert Gillies, David Morse

Keywords(s):

Category(s): Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Biomarkers